Skip to content
WeighLab
Menu
Ranked #300 · Grade C

Lemonaid Health review

Telehealth platform offering some of the lowest entry-tier GLP-1 program pricing on the market.

Visit Lemonaid Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$348/mo (starting dose, plus a separate fee, compounded)
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$4,176

The Index scorecard

Lemonaid Health scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month20/100
Price Transparency64/100
Nationwide Access86/100
Formulation Options53/100
Clinical Oversight74/100
Contract Flexibility41/100

Where the value is

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The tradeoffs

  • Limited public information on program details

The bottom line

Best for: Cost-first shoppers who want budget-conscious shoppers. Telehealth platform offering some of the lowest entry-tier GLP-1 program pricing on the market.

Ranked #300 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Lemonaid Health.

The 18 programs nearest this one

Pricing, states and verification reflect Lemonaid Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Lemonaid Health's site. Not medical advice; see our disclosure.

← Back to the value leaderboard